Kidney Diseases
3 competing products in clinical development for Kidney Diseases.
Pipeline by Phase
Phase 1/21
Phase 21
Approved1
All Products (3)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Regadenoson + Placebo | Astellas Pharma | Approved | Completed | 43 |
| Daclizumab + Mycophenolate mofetil (MMF) + Prednisone + Tacrolimus + Ganciclovir + Valganciclovir + Trimethoprim and sulfamethoxazole | Astellas Pharma | Phase 1/2 | Completed | 32 |
| everolimus and tacrolimus | Astellas Pharma | Phase 2 | UNKNOWN | 31 |